A diabetologist’s perspective of non‐alcoholic steatohepatitis (NASH): Knowledge gaps and future directions-Reference-Cited by-同舟云学术

A diabetologist’s perspective of non‐alcoholic steatohepatitis (NASH): Knowledge gaps and future directions

Published:2020-02 Issue:S1 Volume:40 Page:82-88
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Cusi Kenneth¹²

Affiliation:

1. Division of Endocrinology, Diabetes and Metabolism University of Florida Gainesville FL USA

2. Malcom Randall Veterans Administration Medical Center Gainesville FL USA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14350

Reference57 articles.

1. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

2. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

3. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients

4. Economic and clinical burden of non‐alcoholic steatohepatitis (NASH) in patients with type 2 diabetes mellitus (T2DM) in the United States;Younossi Z;Diabetes Care

5. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-drug delivery systems (NDDS) in metabolic dysfunction-associated steatotic liver disease (MASLD): current status, prospects and challenges;Frontiers in Pharmacology;2024-08-06

2. The significance of glutaredoxins for diabetes mellitus and its complications;Redox Biology;2024-05

3. Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome;iScience;2024-02

4. Nonalcoholic Fatty Liver Disease in Diabetes: A Call to Action;Diabetes Spectrum;2024-02-01

5. Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know;Diabetes Spectrum;2024-02-01